PDS Biotechnology Corp (PDSB) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 18 transactions totaling $476.6K, demonstrating a bullish sentiment with $476.6K in net insider flow. The most recent transaction on Dec 2, 2022 involved a transaction of 219,535 shares valued at $1.4M.
No significant insider buying has been recorded for PDSB in the recent period.
No significant insider selling has been recorded for PDSB in the recent period.
Based on recent SEC filings, insider sentiment for PDSB is bullish with an Insider Alignment Score of 100/100 and a net flow of $476.6K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at PDS Biotechnology Corp (PDSB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading PDSB stock, having executed 18 transactions in the past 90 days. The most active insider is Frank Bedu-addo (Executive), who has made 4 transactions totaling $3.9M.
Get notified when executives and directors at PDSB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 2, 2022 | Bedu-addo Frank | Executive | Option Exercise | 219,535 | $6.57 | $1.4M | Large |
| Dec 2, 2022 | Bedu-addo Frank | Executive | Payment | 175,184 | $9.78 | $1.7M | Large |
| Dec 13, 2021 | C. Hill Matthew | Executive | Purchase | 100 | $9.00 | $900 | |
| Dec 13, 2021 | C. Hill Matthew | Executive | Purchase | 100 | $9.00 | $900 | |
| Dec 13, 2021 | C. Hill Matthew | Executive | Purchase | 400 | $8.90 | $3.6K | |
| Dec 13, 2021 | C. Hill Matthew | Executive | Purchase | 2,500 | $9.00 | $22.5K | |
| Jun 16, 2021 | W. Bloomquist Delyle | Executive | Option Exercise | 2,970 | $5.99 | $17.8K | |
| Jun 16, 2021 | W. Bloomquist Delyle | Executive | Purchase | 10,000 | $9.88 | $98.8K | |
| Jun 15, 2021 | Gene Freitag Gregory | Executive | Purchase | 5,882 | $8.50 | $50.0K | |
| Jun 15, 2021 | Seth Van Voorhees | Executive | Purchase | 17,647 | $8.50 | $150.0K | |
| Jun 15, 2021 | Ali-jackson Kamil | Executive | Purchase | 11,764 | $8.50 | $100.0K | |
| Jun 15, 2021 | C. Glover Steve | Executive | Purchase | 5,882 | $8.50 | $50.0K | |
| Jun 15, 2021 | Bedu-addo Frank | Executive | Option Exercise | 53,174 | $6.57 | $349.4K | |
| Jun 15, 2021 | Bedu-addo Frank | Executive | Payment | 27,166 | $12.86 | $349.4K | |
| Feb 14, 2020 | C. Glover Steve | Executive | Award | 38,400 | $1.30 | $49.9K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Payment(F) | 2 | $2.1M | 41.3% |
Exercise(M) | 3 | $1.8M | 36.2% |
Award(A) | 4 | $649.8K | 13.0% |
Purchase(P) | 9 | $476.6K | 9.5% |
Insiders at PDS Biotechnology Corp are accumulating shares at an accelerated pace. With 9 insiders making 18 transactions totaling $476.6K in purchases versus $0 in sales, the net buying activity of $476.6K signals strong executive confidence. Frank Bedu-addo (Executive) leads the buying activity with $3.9M in transactions across all time.